Literature DB >> 15955426

TrkA NGF receptor plays a role in the modulation of p75NTR expression.

Sherri L Rankin1, Clifford S Guy, Karen M Mearow.   

Abstract

The cellular response to nerve growth factor (NGF) is mediated by two structurally unrelated receptors, TrkA and p75 neurotrophin receptor (p75NTR), which have been shown to interact resulting in reciprocal modulation of function. In this study, we have examined the modulation of p75NTR protein expression by specific TrkA autophosphorylation sites in the presence or absence of NGF. We have used cell lines derived from PC12 cells that express either no endogenous TrkA (PC12nnr5) or TrkA receptors mutated via site-directed mutagenesis to abrogate individual tyrosine autophosphorylation sites on the cytoplasmic tail (Y490F, Y785F and Y490/785F). Results indicate that in the absence of TrkA in PC12nnr5 cells there is reduced constitutive p75NTR expression, which can be restored to different degrees by transfection of the Y490F TrkA or the Y490/785F TrkA, but not by transfection of the Y785F TrkA. In addition, the expression of p75NTR was upregulated in the presence of NGF in the parental and Y490F cell lines only. Together these results indicate a role for the individual tyrosine autophosphorylation sites of TrkA in regulating p75NTR expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955426     DOI: 10.1016/j.neulet.2005.04.043

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Messenger RNA expression patterns of p75 neurotrophin receptor and tropomyosin-receptor-kinase A following spinal cord injury.

Authors:  Fatemeh Montazeri; Abolghasem Esmaeili; Mehran Miroliaei; Sayed Jamal Moshtaghian
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

2.  Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].

Authors:  M M H Al-Gayyar; S Matragoon; B A Pillai; T K Ali; M A Abdelsaid; A B El-Remessy
Journal:  Diabetologia       Date:  2010-12-07       Impact factor: 10.122

3.  Chemical genetics identifies small-molecule modulators of neuritogenesis involving neuregulin-1/ErbB4 signaling.

Authors:  Letian Kuai; Xiang Wang; Jon M Madison; Stuart L Schreiber; Edward M Scolnick; Stephen J Haggarty
Journal:  ACS Chem Neurosci       Date:  2010-01-28       Impact factor: 4.418

Review 4.  Neurotrophic factors and their effects in the treatment of multiple sclerosis.

Authors:  Shahnaz Razavi; Ghasemi Nazem; Mohammad Mardani; Ebrahim Esfandiari; Hossein Salehi; Sayyed Hamid Zarkesh Esfahani
Journal:  Adv Biomed Res       Date:  2015-02-17

5.  Chronic TrkB agonist treatment in old age does not mitigate diaphragm neuromuscular dysfunction.

Authors:  Sarah M Greising; Amrit K Vasdev; Wen-Zhi Zhan; Gary C Sieck; Carlos B Mantilla
Journal:  Physiol Rep       Date:  2017-01

6.  Targeted delivery of TrkB receptor to phrenic motoneurons enhances functional recovery of rhythmic phrenic activity after cervical spinal hemisection.

Authors:  Heather M Gransee; Wen-Zhi Zhan; Gary C Sieck; Carlos B Mantilla
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

7.  Implication of the neurotrophin receptor p75NTR in vascular diseases: beyond the eye.

Authors:  Sally L Elshaer; Azza B El-Remessy
Journal:  Expert Rev Ophthalmol       Date:  2016-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.